Matthieu Grégoire

University Name

France

Research Interests

Explore related searches

Professors in France

Contact this professor

ORCID

Google Scholar

Articles (10)

Therapeutic drug monitoring and virological response at week 48 in a cohort of HIV‐1‐infected patients switching to dolutegravir/rilpivirine dual maintenance therapy (ANRS‐MIE‐BIRIDER study)

Article Link

Year:

2023

TEMPORARY REMOVAL: Expert Opinion on Dose Regimen and Therapeutic Drug Monitoring for Long-Term Use of Dalbavancin: Expert Review Panel

Article Link

Year:

2023

Response to “<scp>CYP450 3A4</scp>/5 Containment During <scp>SARS‐CoV</scp>‐2 Infection”

Article Link

Year:

2022

Impact of Inflammation on Midazolam Metabolism in Severe COVID‐19 Patients

Article Link

Year:

2022

A murine model to study the gut bacteria parameters during complex antibiotics like cefotaxime and ceftriaxone treatment

Article Link

Year:

2021

CYP1A2 and tobacco interaction: a major pharmacokinetic challenge during smoking cessation

Article Link

Year:

2021

Phages versus Antibiotics To Treat Infected Diabetic Wounds in a Mouse Model: a Microbiological and Microbiotic Evaluation

Article Link

Year:

2020

PK/PD targets of amikacin and gentamicin in ICU patients

Article Link

Year:

2020

Development and validation of a dosing nomogram for amoxicillin in infective endocarditis

Article Link

Year:

2020

Potential drug–drug interactions associated with drugs currently proposed for COVID‐19 treatment in patients receiving other treatments

Article Link

Year:

2020

Collaborators (3)

Pascale Bémer

Nantes University Hospital

FRANCE

Alex Soriano

University of Barcelona

SPAIN

François Javaudin

Université de Nantes

FRANCE

Matthieu Grégoire

Research Interests

Explore related searches

Contact this professor

Articles (10)

Therapeutic drug monitoring and virological response at week 48 in a cohort of HIV‐1‐infected patients switching to dolutegravir/rilpivirine dual maintenance therapy (ANRS‐MIE‐BIRIDER study)

TEMPORARY REMOVAL: Expert Opinion on Dose Regimen and Therapeutic Drug Monitoring for Long-Term Use of Dalbavancin: Expert Review Panel

Response to “<scp>CYP450 3A4</scp>/5 Containment During <scp>SARS‐CoV</scp>‐2 Infection”

Impact of Inflammation on Midazolam Metabolism in Severe COVID‐19 Patients

A murine model to study the gut bacteria parameters during complex antibiotics like cefotaxime and ceftriaxone treatment

CYP1A2 and tobacco interaction: a major pharmacokinetic challenge during smoking cessation

Phages versus Antibiotics To Treat Infected Diabetic Wounds in a Mouse Model: a Microbiological and Microbiotic Evaluation

PK/PD targets of amikacin and gentamicin in ICU patients

Development and validation of a dosing nomogram for amoxicillin in infective endocarditis

Potential drug–drug interactions associated with drugs currently proposed for COVID‐19 treatment in patients receiving other treatments

Collaborators (3)

Pascale Bémer

Alex Soriano

François Javaudin

How do I reach out?

Meet Kite AI